141 related articles for article (PubMed ID: 8583857)
21. Differential expression of human beta defensin 2 and human beta defensin 3 in human middle ear cholesteatoma.
Song JJ; Chae SW; Woo JS; Lee HM; Jung HH; Hwang SJ
Ann Otol Rhinol Laryngol; 2007 Mar; 116(3):235-40. PubMed ID: 17419529
[TBL] [Abstract][Full Text] [Related]
22. Increased permeability of the epithelium of middle ear cholesteatoma.
Koizumi H; Suzuki H; Ohbuchi T; Kitamura T; Hashida K; Nakamura M
Clin Otolaryngol; 2015 Apr; 40(2):106-14. PubMed ID: 25319490
[TBL] [Abstract][Full Text] [Related]
23. Different production of interleukin-1alpha, interleukin-1beta and interleukin-8 from cholesteatomatous and normal epithelium.
Chung JW; Yoon TH
Acta Otolaryngol; 1998 Jun; 118(3):386-91. PubMed ID: 9655214
[TBL] [Abstract][Full Text] [Related]
24. Acquired and congenital cholesteatoma: determination of tumor necrosis factor-alpha, intercellular adhesion molecule-1, interleukin-1-alpha and lymphocyte functional antigen-1 in the inflammatory process.
Akimoto R; Pawankar R; Yagi T; Baba S
ORL J Otorhinolaryngol Relat Spec; 2000; 62(5):257-65. PubMed ID: 10965261
[TBL] [Abstract][Full Text] [Related]
25. [Immunohistochemical detection of c-myc proto-oncogene products in middle ear cholesteatoma].
Holly A; Sittinger M; Bujía J
Laryngorhinootologie; 1995 Jun; 74(6):348-51. PubMed ID: 7662077
[TBL] [Abstract][Full Text] [Related]
26. Activation of the IL-6/JAK/STAT3 signaling pathway in human middle ear cholesteatoma epithelium.
Liu W; Xie S; Chen X; Rao X; Ren H; Hu B; Yin T; Xiang Y; Ren J
Int J Clin Exp Pathol; 2014; 7(2):709-15. PubMed ID: 24551293
[TBL] [Abstract][Full Text] [Related]
27. [Activation of nuclear factor-kappaB and aberrant gene expression of interleukin 6 in middle ear cholesteatoma].
Xu Y; Tao ZZ; Hua QQ; Wang XC; Xiao BK; Chen SM
Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2009 Mar; 44(3):192-6. PubMed ID: 19558856
[TBL] [Abstract][Full Text] [Related]
28. [Hexosoaminidase gene expression in cholesteatoma in adults].
Rutkowska J; Olszewska E; Waniewska E; Czechowska S; Kowalczuk O; Borawska M; Zukowska M; Markiewicz R; Rogowski M
Otolaryngol Pol; 2009; 63(6):490-5. PubMed ID: 20198983
[TBL] [Abstract][Full Text] [Related]
29. Expression of a cathelicidin antimicrobial peptide is augmented in cholesteatoma.
Jung HH; Chae SW; Jung SK; Kim ST; Lee HM; Hwang SJ
Laryngoscope; 2003 Mar; 113(3):432-5. PubMed ID: 12616192
[TBL] [Abstract][Full Text] [Related]
30. [A quantitative study of the presence of interleukin-1 and interleukin-6 in cholesteatoma of the middle ear].
Aumente PO; Bujía J; Kim C; Jiménez Giménez J; López Villarejo P
Acta Otorrinolaringol Esp; 1996; 47(4):259-62. PubMed ID: 8962724
[TBL] [Abstract][Full Text] [Related]
31. Activation of NLRP3 inflammasome in human middle ear cholesteatoma and chronic otitis media.
Kariya S; Okano M; Zhao P; Kataoka Y; Yoshinobu J; Maeda Y; Ishihara H; Higaki T; Nishizaki K
Acta Otolaryngol; 2016; 136(2):136-40. PubMed ID: 26457439
[TBL] [Abstract][Full Text] [Related]
32. [Immunological problems in middle ear cholesteatoma].
Olszewska E; Chodynicki S
Otolaryngol Pol; 2004; 58(1):85-90. PubMed ID: 15101265
[TBL] [Abstract][Full Text] [Related]
33. p53 Expression and keratinocyte hyperproliferation in middle ear cholesteatoma.
Motamed M; Powe D; Kendall C; Birchall JP; Banerjee AR
Clin Otolaryngol Allied Sci; 2002 Dec; 27(6):505-8. PubMed ID: 12472520
[TBL] [Abstract][Full Text] [Related]
34. The nature of the epithelium in acquired cholesteatoma: Part 3--Cytokeratin patterns in aural epithelial and cholesteatoma cells grown in cell culture.
Lee RJ; Sidey C; Narula AA; James RF
Clin Otolaryngol Allied Sci; 1994 Dec; 19(6):516-20. PubMed ID: 7534665
[TBL] [Abstract][Full Text] [Related]
35. Differential gene expression in cholesteatoma by DNA chip analysis.
Macias JD; Gerkin RD; Locke D; Macias MP
Laryngoscope; 2013 Oct; 123 Suppl S5():S1-21. PubMed ID: 23670528
[TBL] [Abstract][Full Text] [Related]
36. Notch Signaling in Acquired Middle Ear Cholesteatoma.
Fukuda A; Kano S; Nakamaru Y; Morita S; Hoshino K; Fujiwara K; Homma A
Otol Neurotol; 2021 Oct; 42(9):e1389-e1395. PubMed ID: 34172659
[TBL] [Abstract][Full Text] [Related]
37. Caspase-3, caspase-8, and nuclear factor-kappaB expression in human cholesteatoma.
Miyao M; Shinoda H; Takahashi S
Otol Neurotol; 2006 Jan; 27(1):8-13. PubMed ID: 16371840
[TBL] [Abstract][Full Text] [Related]
38. Overexpression of ErbB-2 protein in human middle ear cholesteatomas.
Sakamoto T; Kondo K; Yamasoba T; Suzuki M; Sugasawa M; Kaga K
Laryngoscope; 2004 Nov; 114(11):1988-91. PubMed ID: 15510028
[TBL] [Abstract][Full Text] [Related]
39. Interleukin-1 alpha, interleukin-1 beta and interleukin-8 gene expression in human aural cholesteatomas.
Kim CS; Lee CH; Chung JW; Kim CD
Acta Otolaryngol; 1996 Mar; 116(2):302-6. PubMed ID: 8725537
[TBL] [Abstract][Full Text] [Related]
40. Expression of secretory leukocyte protease inhibitor in middle ear cholesteatoma.
Lee JK; Chae SW; Cho JG; Lee HM; Hwang SJ; Jung HH
Eur Arch Otorhinolaryngol; 2006 Dec; 263(12):1077-81. PubMed ID: 16868773
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
